Reviewed condensed consolidated annual financial statements and unreviewed production and sales volumes information for the year ended 31 December 2017

at 31 December

	2017 Reviewed Rm	2016 Audited Rm
ASSETS
Non-current assets	47 706	49 959
Property, plant and equipment	24 362	21 972
Biological assets	34	45
Intangible assets	17	31
Investments in associates (note 14)	15 810	21 518
Investments in joint ventures (note 15)	1 479	1 258
Financial assets (note 16)	5 433	4 720
Deferred tax	571	415
Current assets	10 936	9 842
Inventories	1 055	1 036
Financial assets (note 16)	48	480
Trade and other receivables	3 199	3 050
Current tax receivable	28	81
Cash and cash equivalents	6 606	5 195
Non-current assets held-for-sale (note 17)	3 910	130
Total assets	62 552	59 931
EQUITY AND LIABILITIES
Capital and other components of equity
Share capital	1 021	2 509
Other components of equity	8 120	2 085
Retained earnings	30 962	31 281
Equity attributable to owners of the parent	40 103	35 875
Non-controlling interests	(738)	(788)
Total equity	39 365	35 087
Non-current liabilities	17 409	16 282
Interest-bearing borrowings (note 18)	6 480	6 002
Provisions	3 864	4 162
Post-retirement employee obligations	227	239
Financial liabilities (note 20)	850	479
Deferred tax	5 988	5 400
Current liabilities	4 127	7 461
Trade and other payables	3 237	3 010
Shareholder loans		18
Interest-bearing borrowings (note 18)	2	503
Current tax payable	368	210
Financial liabilities (note 20)	371	3 599
Provisions	95	109
Overdraft (note 18)	54	12
Non-current liabilities held-for-sale (note 17)	1 651	1 101
Total liabilities	23 187	24 844
Total equity and liabilities	62 552	59 931